Publications

Basta G (2008). Receptor for advanced glycation endproducts and atherosclerosis: From basic mechanisms to clinical implications. Atherosclerosis 196: 9-21. http://dx.doi.org/10.1016/j.atherosclerosis.2007.07.025 PMid:17826783 Bierhaus A, Humpert PM, Morcos M, Wendt T, et al. (2005). Understanding RAGE, the receptor for advanced glycation end products. J. Mol. Med. 83: 876-886. http://dx.doi.org/10.1007/s00109-005-0688-7 PMid:16133426 Chua KH, Kee BP, Tan SY and Lian LH (2009). Interleukin-6 promoter polymorphisms (-174 G/C) in Malaysian patients with systemic lupus erythematosus (SLE). Braz. J. Med. Biol. Res. 42: 551-555. http://dx.doi.org/10.1590/S0100-879X2009000600012 PMid:19448905 Chua KH, Puah SM, Chew CH, Tan SY, et al. (2010). Study of the CTLA-4 gene polymorphisms in systemic lupus erythematosus (SLE) samples from Malaysia. Ann. Hum. Biol. 37: 275-281. http://dx.doi.org/10.3109/03014460903325185 PMid:19951233 dos Santos KG, Canani LH, Gross JL, Tschiedel B, et al. (2005). The -374A allele of the receptor for advanced glycation end products gene is associated with a decreased risk of ischemic heart disease in African-Brazilians with type 2 diabetes. Mol. Genet. Metab. 85: 149-156. http://dx.doi.org/10.1016/j.ymgme.2005.02.010 PMid:15896660 Esteves J, Laranjeira AF, Roggia MF, Dalpizol M, et al. (2008). Diabetic retinopathy risk factors. Arq. Bras. Endocrinol. Metabol. 52: 431-441. PMid:18506268 ETDRS (1991a). Fundus photographic risk factors for progression of diabetic retinopathy. ETDRS report number 12. Early Treatment Diabetic Retinopathy Study Research Group. Ophthalmology 98: 823-833. PMid:2062515 ETDRS (1991b). Grading diabetic retinopathy from stereoscopic color fundus photographs - an extension of the modified Airlie House classification. ETDRS report number 10. Early Treatment Diabetic Retinopathy Study Research Group. Ophthalmology 98: 786-806. PMid:2062513 Hallman DM, Huber JC Jr, Gonzalez VH, Klein BE, et al. (2005). Familial aggregation of severity of diabetic retinopathy in Mexican Americans from Starr County, Texas. Diabetes Care 28: 1163-1168. http://dx.doi.org/10.2337/diacare.28.5.1163 PMid:15855583 Hietala K, Forsblom C, Summanen P and Groop PH (2008). Heritability of proliferative diabetic retinopathy. Diabetes 57: 2176-2180. http://dx.doi.org/10.2337/db07-1495 PMid:18443200    PMCid:2494680 Hudson BI, Stickland MH and Grant PJ (1998). Identification of polymorphisms in the receptor for advanced glycation end products (RAGE) gene: prevalence in type 2 diabetes and ethnic groups. Diabetes 47: 1155-1157. http://dx.doi.org/10.2337/diabetes.47.7.1155 PMid:9648842 Hudson BI, Stickland MH, Futers TS and Grant PJ (2001). Effects of novel polymorphisms in the RAGE gene on transcriptional regulation and their association with diabetic retinopathy. Diabetes 50: 1505-1511. http://dx.doi.org/10.2337/diabetes.50.6.1505 PMid:11375354 JiXiong X, BiLin X, MingGong Y and ShuQin L (2003). -429T/C and -374T/A polymorphisms of RAGE gene promoter are not associated with diabetic retinopathy in Chinese patients with type 2 diabetes. Diabetes Care 26: 2696-2697. Kalousova M, Zima T, Tesar V, Dusilova-Sulkova S, et al. (2005). Advanced glycoxidation end products in chronic diseases - clinical chemistry and genetic background. Mutat. Res. 579: 37-46. http://dx.doi.org/10.1016/j.mrfmmm.2005.03.024 PMid:16084533 Kalousova M, Jachymova M, Mestek O, Hodkova M, et al. (2007). Receptor for advanced glycation end products - soluble form and gene polymorphisms in chronic haemodialysis patients. Nephrol. Dial. Transplant. 22: 2020-2026. http://dx.doi.org/10.1093/ndt/gfm050 PMid:17347281 Kankova K, Zahejsky J, Marova I, Muzik J, et al. (2001). Polymorphisms in the RAGE gene influence susceptibility to diabetes-associated microvascular dermatoses in NIDDM. J. Diabetes Complications 15: 185-192. http://dx.doi.org/10.1016/S1056-8727(00)00135-5 Kankova K, Beranek M, Hajek D and Vlkova E (2002). Polymorphisms 1704G/T, 2184A/G, and 2245G/A in the rage gene are not associated with diabetic retinopathy in NIDDM: pilot study. Retina 22: 119-121. http://dx.doi.org/10.1097/00006982-200202000-00026 Klein R, Klein BE, Moss SE, Davis MD, et al. (1984). The Wisconsin epidemiologic study of diabetic retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch. Ophthalmol. 102: 527- 532. http://dx.doi.org/10.1001/archopht.1984.01040030405011 PMid:6367725 Kumaramanickavel G, Ramprasad VL, Sripriya S, Upadyay NK, et al. (2002). Association of Gly82Ser polymorphism in the RAGE gene with diabetic retinopathy in type II diabetic Asian Indian patients. J. Diabetes Complications 16: 391-394. http://dx.doi.org/10.1016/S1056-8727(02)00187-3 Liu L and Xiang K (1999). RAGE Gly82Ser polymorphism in diabetic microangiopathy. Diabetes Care 22: 646. http://dx.doi.org/10.2337/diacare.22.4.646 PMid:10189547 Roy MS, Hallman DM, Fu YP, Machado M, et al. (2009). Assessment of 193 candidate genes for retinopathy in African Americans with type 1 diabetes. Arch. Ophthalmol. 127: 605-612. http://dx.doi.org/10.1001/archophthalmol.2009.48 PMid:19433708 Salman AG, Mansour DE, Swelem AH, Al-Zawahary WM, et al. (2009). Pentosidine - a new biochemical marker in diabetic retinopathy. Ophthalmic Res. 42: 96-98. http://dx.doi.org/10.1159/000225661 PMid:19546600 Schlueter C, Hauke S, Flohr AM, Rogalla P, et al. (2003). Tissue-specific expression patterns of the RAGE receptor and its soluble forms - a result of regulated alternative splicing? Biochim. Biophys. Acta 1630: 1-6. http://dx.doi.org/10.1016/j.bbaexp.2003.08.008 The Diabetic Retinopathy Study Research Group (1981). A modification of the Airlie House Classification of Diabetic Retinopathy: Diabetic Retinopathy Study report number 7. Invest. Opthalmol. Vis. Sci. 21: 210-226. Uthra S, Raman R, Mukesh BN, Rajkumar SA, et al. (2008). Association of VEGF gene polymorphisms with diabetic retinopathy in a south Indian cohort. Ophthalmic Genet. 29: 11-15. http://dx.doi.org/10.1080/13816810701663527 PMid:18363167 Yamamoto T, Hosoi M, Sato T, Miyamoto M, et al. (2000). Gly82Ser polymorphism in the receptor for advanced glycation end products (RAGE) gene is not associated with the progression of diabetic nephropathy and retinopathy in Japanese patients with type 1 diabetes mellitus: Findings from 20 years of follow-up. Diabetes 49: A402. Yoshioka K, Yoshida T, Takakura Y, Umekawa T, et al. (2005). Relation between polymorphisms G1704T and G82S of rage gene and diabetic retinopathy in Japanese type 2 diabetic patients. Intern. Med. 44: 417-421. http://dx.doi.org/10.2169/internalmedicine.44.417 PMid:15942086 Zhang HM, Chen LL, Wang L, Liao YF, et al. (2009). Association of 1704G/T and G82S polymorphisms in the receptor for advanced glycation end products gene with diabetic retinopathy in Chinese population. J. Endocrinol. Invest. 32: 258-262. PMid:19542745